Design of an expert system for the development and formulation of push-pull osmotic pump tablets containing poorly water-soluble drugs

International Journal of Pharmaceutics

Volumn 410, Issue 1-2, 2011, Pages 41-47

  Zhang, Zhi Hong ^a,b   Dong, Hong Ye ^a   Peng, Bo ^a   Liu, Hong Fei ^c   Li, Chun Lei ^b   Liang, Min ^b   Pan, Wei San ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b Shijiazhuang Pharmaceutical Group   (China)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Artificial neural network; Expert system; Formulation design; Poorly water soluble drugs; Push pull osmotic pump (PPOP)

Indexed keywords

DIPYRIDAMOLE; FAMOTIDINE; GLIPIZIDE; INDAPAMIDE; NIFEDIPINE; WATER;

ARTICLE; ARTIFICIAL INTELLIGENCE; ARTIFICIAL NEURAL NETWORK; DRUG DESIGN; DRUG RELEASE; DRUG SOLUBILITY; OSMOTIC PUMP; PRIORITY JOURNAL; PUSH PULL OSMOTIC PUMP TABLET; TABLET FORMULATION;

DRUG DELIVERY SYSTEMS; EXCIPIENTS; FAMOTIDINE; MODELS, THEORETICAL; NEURAL NETWORKS (COMPUTER); OSMOSIS; SOLUBILITY;

EID: 79955579561     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.03.013     Document Type: Article

References (24)

1. Aguilar, J.E., Garcia, E., Perez, P., Suñé-Negre, J.M., Miñarro, M., Ticó, J.R., 2009. The use of the SeDeM Diagram expert system to determine the suitability of diluents-disintegrants for direct compression and their use in formulation of ODT. Eur. J. Pharm. Biopharm. 73, 414-423.
2. Aleksander, M., Renata, J., 2007. Unified methodology of neural analysis in decision support systems built for pharmaceutical technology. Expert Syst. Appl. 32, 1124-1131.
3. Batrman, S.D., Jerome, V., Mark, R., 1996. The development and validation of a capsule formulation knowledge-based system. Pharm. Technol. 20, 174-184.
4. Cai, Z.X., Xu, G.Y., 2004. Artificial Intelligence: Principles and Applications. Tsinghua University Press, Beijing.
5. Chen, C.X., Li, S.M., Li, H.J., Sun, Y.H., 2007. Preparation of monolithic osmotic pump tablets of famotidine. Chin. New Drug J. 16, 1035-1038.
6. Lai, S., Podczeck, F., Newton, J.M., Daumesnil, R., 1996. An expert system to aid the development of capsule formulation. Pharm. Technol. Eur. 10, 60-68.
7. Liu, L., Khang, G., Rhee, J.M., Lee, H.B., 2000. Monolithic osmotic tablet system for nifedipine delivery. J. Control. Release 67, 309-322. (Pubitemid 30303844)
8. Lu, E.X., Jiang, Z.Q., Zhang, Q.Z., Jiang, X.G., 2002. Preparation of controlled release coated tablets of naproxen sodium. Chin. Pharm. J. 37, 841-844.
9. Okimoto, K., Rajewski, R.A., Stella, V.J., 1999. Release of testosterone from an osmotic pumptablet utilizing (SBE) 7m-β-CD as both a solubilizing and an osmotic pump agent. J. Control. Release 58, 29-38. (Pubitemid 29371811)
10. Okimoto, K., Tokunaga, Y., Ibuki, R., Irie, T., Uekama, K., Rajewski, R.A., Stella, V.J., 2004. Applicability of (SBE) 7m-β-CD in controlled-porosity osmotic pump tablets (OPTs). Int. J. Pharm. 286, 81-88. (Pubitemid 39410475)
11. Ouyang, D.F., Nie, S.F., Li, W., Guo, H., Liu, H., Pan, W.S., 2005. In vitro and in vivo evaluation of two extended release preparations of combination metformin and glipizide. Drug Dev. Ind. Pharm. 31, 677-685.
12. Perez, P., Suñé-Negre, J.M., Miñarro, M., Roig, M., Fuster, R., Garcia, E., Hernández, C., Ruhí, R., Ticó, J.R., 2006.Anewexpert systems (SeDeM Diagram) for control batch powder formulation and preformulation drug products. Eur. J. Pharm. Biopharm. 64, 351-359.
13. Rowe, R.C., 1993. Expert systems in solid dosage development. Pharm. Ind. 55, 1040.
14. Rowe, R.C., Wakerly, M.G., Roberts, R.J., Grundy, R.U., 1995. Expert systems for parenteral development. PDAJ, Pharm. Sci. Technol. 49, 257-261.
15. Rowe, R.C., Roberts, R.J., 1998. Artificial intelligence in pharmaceutical product formulations: knowledge-based and expert systems. Pharm. Sci. Technol. Today 1, 153-159.
16. Rowe, R.C., Han, J., Roberts, R.J., 1998. Film coating formulation using an expert system. Pharm. Technol. Eur. 10, 72-82.
17. Shah, V.P., Tsong, Y., Sathe, P., Liu, J., 1998. In vitro dissolution profile comparison-statistics and analysis of the similarity factor, f2. Pharm. Res. 15, 889-896.
18. Theeuwes, F., Higuchi, T., 1972. Osmotic dispensing device for releasing beneficial agent. US Patent 3,845,770.
19. Theeuwes, F., 1975. Elementary osmotic pump. J. Pharm. Sci. 64, 1987-1991.
20. Theeuwes, F., 1978. Osmotic system for delivering selected beneficial agents having varying degrees of solubility. US Patent 4,111,201, 5 September.
21. Verma, R., Mishra, B., Garg, S., 2000. Osmotically controlled oral drug delivery. Drug Dev. Ind. Pharm. 26, 695-708.
22. Yannis, L.L., 1998. A computer-based expert system designs and analyzes a 2(k-p) fractional factorial design for the formulation optimization of novel multicomponent liposomes. J. Pharm. Biomed. Anal. 17, 133-140.
23. Zhang, Z.H., Li, W., Nie, S.F., Tang, X., Peng, B., Tian, L., Pan, W.S., 2009. Overcome side identification in PPOP by making orifices on both layers. Int. J. Pharm. 371, 1-9.
24. Zhang, L., Chen, D., Li, F.J., Song, A.H., Kui, G.B., 2001. Studies on the absorption kinetics of famotidine in rats' intestines. J. Shenyang Pharm. Univ. 18, 170-172.